IATI (Israeli Advanced Technology Industries), as the voice of the industry and as the Israeli Umbrella Organization for the high-tech and life science industries, aims to promote and position the high-tech and life science industries as leading Israeli and global trades.
IATI has uniquely created a joint platform to promote all levels of the Israeli tech ecosystem, with its 700 paying members: entrepreneurs, startups and growth companies, incubators, accelerators, R&D centers of MNCs, local and international VCs, hospitals, academic institutes, TTOs, municipalities, service providers and more.
IATI actively generates local and global business opportunities for our members. We do so through our extensive activity, which includes global networking, business development, encouraging local Israeli investment in the tech industries, promotion of STEM education, and taking leading roles in substantial events and conferences.
IATI leads strategic initiatives by working closely with the Israeli government and Parliament and creating solutions to pressing industry issues. IATI advocates for public policies and legislation that encourage Israeli innovation and entrepreneurship.
IATI engages, on behalf of the industry, in strategic cooperation agreements with various foreign countries and regions, to promote mutual R&D and trade interests and provide our members with access to top-tier R&D, marketing, and financial service providers, venture capital investors, top-tier global delegations, and much more.
“Israel’s Life Sciences Industry offers a sweeping panorama of the country’s flourishing life sciences industry, which is growing in prominence in the global healthcare market,” said Yaky Yanay, IATI Co-Chairman and Pluristem Therapeutics Co-CEO and President. “The Conference and Exhibition provides a taste of various aspects of the industry, from current trends and influences to systematic elements including continued government support and academic excellence.”
He added, “The Israeli Life Sciences Industry has accelerated rapidly, with a growing pipeline in a variety of industry segments. This growth is aided by consistent government support and a strong academic base, which is a leading source for companies and technologies within the ecosystem.”
IATI CEO Karin Mayer Rubinstein said, “We at IATI, as the voice of the industry, provide solutions to pushing matters influencing the local industry. By connecting the tech ecosystem in Israel, we encourage collaboration between the country’s experienced and highly-educated professionals, an outstanding academic community, innovative spirit and technological prowess, which we believe will only continue to propel Israel’s life sciences industry even further in the coming years. We expect more cooperation between multinational and local players to bring revolutionary treatments and solutions to people around the world.”
She continued, “This Conference and Exhibition provides an in-depth view of the local industry, highlighting the sustained growth and progress that has been made and helps give visitors an idea of where the industry is headed. We hope that you will find your visit to be informative and helpful, and encourage you to share what you see with others. We are at your service and happy to hear your voice – send us your feedback, opinions and advice, so we can learn and improve towards the next MIXiii Biomed.”